Sethi et al. reported a case series of ten patients with largely Rituximab-refractory membranous nephropathy (six of whom were PLA2R-positive on serum or biopsy, and four of whom had a transplant) [10]. Here, PLA2R1 is linked to membranous glomerulonephritis.